A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

Clinical trial NCT03911128 · RECRUITING

Trial details

NCT number: NCT03911128
Sponsor: Mats Heyman
Status: RECRUITING
Study type: OBSERVATIONAL

Leukemia, Acute Lymphoblastic

Start date: 2019-08-29
Primary completion: 2033-06-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.